$1.02
3.77% today
Nasdaq, Apr 03, 06:46 pm CET
ISIN
US91381U1016
Symbol
UBX
Sector
Industry

Unity Biotechnology, Inc. Target price 2025 - Analyst rating & recommendation

Unity Biotechnology, Inc. Classifications & Recommendation:

Buy
100%

Unity Biotechnology, Inc. Price Target

Target Price $5.60
Price $1.06
Potential
Number of Estimates 5
5 Analysts have issued a price target Unity Biotechnology, Inc. 2026 . The average Unity Biotechnology, Inc. target price is $5.60. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 5 Analysts recommend Unity Biotechnology, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Unity Biotechnology, Inc. stock has an average upside potential 2026 of . Most analysts recommend the Unity Biotechnology, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.54 -1.03
42.96% 33.12%
P/E negative
EV/Sales 45.48

1 Analysts have issued a Unity Biotechnology, Inc. forecast for earnings per share. The average Unity Biotechnology, Inc. EPS is

$-1.03
Unlock
. This is
33.12% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-1.03 33.12%
Unlock
, the lowest is
$-1.03 33.12%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.54 42.96%
2025
$-1.03 33.12%
Unlock
2026
$-1.06 2.91%
Unlock
2027
$-0.24 77.36%
Unlock
2028
$0.88 466.67%
Unlock
2029
$3.44 290.91%
Unlock

P/E ratio

Current -0.69 53.33%
2025
-1.03 49.28%
Unlock
2026
-1.00 2.91%
Unlock
2027
-4.42 342.00%
Unlock
2028
1.20 127.15%
Unlock
2029
0.31 74.17%
Unlock

Current Unity Biotechnology, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Chardan Capital
Locked
Locked
Locked Mar 25 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 25 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 24 2025
Chardan Capital
Locked
Locked
Locked Mar 10 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 10 2025
Chardan Capital
Locked
Locked
Locked Jan 10 2025
Rodman & Renshaw
Locked
Locked
Locked Aug 22 2024
Analyst Rating Date
Locked
Chardan Capital:
Locked
Locked
Mar 25 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 25 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 24 2025
Locked
Chardan Capital:
Locked
Locked
Mar 10 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 10 2025
Locked
Chardan Capital:
Locked
Locked
Jan 10 2025
Locked
Rodman & Renshaw:
Locked
Locked
Aug 22 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today